Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Society for Laboratory Automation and Screening (SLAS)

December 3, 2014 8:56 am | Events

Dynamic industries attract dynamic people. SLAS is proud to be a valued community for more than 18,000 life science research and development professionals from across the globe, including scientists, technology providers, researchers, academics and students, engineers, informatics specialists, and business leaders.

NBC News' Snyderman to Return to Air

December 2, 2014 3:38 pm | by David Bauder - AP Television Writer | News | Comments

 This ends a period where she had been shelved after violating a voluntary quarantine following possible Ebola exposure. Read more...                     

TOPICS:

Officials Designate 35 Hospitals for Ebola Care

December 2, 2014 3:14 pm | by Mike Stobbe - AP Medical Writer | News | Comments

Health officials have designated 35 hospitals across the country as Ebola treatment centers. Read more...                          

TOPICS:
Advertisement

Obama: Ebola Still Priority as Public Focus Shifts

December 2, 2014 3:02 pm | by Jim Kuhnhenn and Stacy A. Anderson - Associated Press | News | Comments

The White House said the Obama administration is making strides in the fight against Ebola. Read more...                          

TOPICS:

Celator Announces DSMB Recommendation to Continue Study of AML Drug

December 2, 2014 12:47 pm | News | Comments

Celator announces that the independent Data and Safety Monitoring Board completed a planned safety review and recommended that the study continue for its AML drug. Read more...              

TOPICS:

Tailor-Made Pharmaceuticals As Basis for Novel Antidepressants

December 2, 2014 12:42 pm | by Max Planck Institute | News | Comments

Scientists at the Max Planck Institute of Psychiatry in Munich have now developed the first potent and highly selective inhibitor for stress-related psychiatric disorders. Read more...             

TOPICS:

Baxter Submits Application for Hemophilia A Treatment

December 2, 2014 12:32 pm | News | Comments

Baxter announced that it has submitted an application for FDA approval of a treatment for hemophilia A. Read more...                        

TOPICS:

Vaccines May Make War on Cancer Personal

December 2, 2014 12:18 pm | by Michael C. Purdy, Washington University in St. Louis | News | Comments

Physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. Read more...                    

TOPICS:
Advertisement

Antacids Linked to Better Survival in Head and Neck Cancer

December 2, 2014 12:03 pm | by University of Michigan | News | Comments

Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival. Read more...                       

TOPICS:

Hackers Target Email At Pharma and Healthcare Companies for Stock Info

December 2, 2014 11:55 am | News | Comments

The team has carried out attacks against nearly 100 publicly traded companies or their advisory firms in possible attempts to play the stock market. Read more...                

TOPICS:

Predicting Alzheimer’s Disease With Blood Tests: Early Detection, Ethical Concerns

December 2, 2014 9:52 am | by Stephanie Guzowski, Editor | Articles | Comments

If you could take a blood test that could detect — with nearly 100% accuracy — whether you were genetically destined to get Alzheimer’s disease, would you take that test? Read more...

TOPICS:

Bayer Receives Canada Approval for Vision Drug

December 2, 2014 9:49 am | News | Comments

Bayer Inc. announced that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). Read more...                             

TOPICS:

New Molecules to Burst Malaria's Bubble

December 2, 2014 9:36 am | by Australian National University | News | Comments

Scientists have released details of a raft of new chemicals with potent anti-malarial properties which could open the way to new drugs to fight the disease. Read more...                                 

TOPICS:

Stressed-Out Cancers May Provide Drug Target

December 2, 2014 9:30 am | by University of Adelaide | News | Comments

Research at the University of Adelaide has discovered cancer cells may be particularly susceptible to metabolic stress - opening the way for new targeted therapy that won't harm normal cells. Read more...                                 

TOPICS:

Otsuka to Buy U.S. Drugmaker Avanir for $3.5B

December 2, 2014 9:22 am | News | Comments

Otsuka Pharmaceutical will spend $3.5 billion in cash to buy Avanir Pharmaceuticals in a deal that expands the Japanese drugmaker's portfolio of neurologic disease treatments. Read more...                         

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading